Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a large drop in short interest in July. As of July 31st, there was short interest totaling 7,620 shares, a drop of 66.5% from the July 15th total of 22,725 shares. Based on an average daily trading volume, of 8,615 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.7% of the shares of the company are short sold.
Hedge Funds Weigh In On Global X HealthTech ETF
A number of hedge funds and other institutional investors have recently made changes to their positions in HEAL. Glenmede Investment Management LP bought a new stake in Global X HealthTech ETF in the third quarter worth about $31,000. Banque Cantonale Vaudoise bought a new position in shares of Global X HealthTech ETF during the 3rd quarter worth $37,000. Royal Bank of Canada increased its holdings in Global X HealthTech ETF by 39.4% in the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after acquiring an additional 736 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Global X HealthTech ETF by 26,522.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after acquiring an additional 2,387 shares during the period. Finally, Farther Finance Advisors LLC bought a new position in Global X HealthTech ETF during the fourth quarter worth about $111,000.
Global X HealthTech ETF Trading Up 0.8%
Shares of HEAL stock traded up $0.24 during trading on Friday, hitting $29.42. The company’s stock had a trading volume of 1,945 shares, compared to its average volume of 10,590. The company has a market cap of $31.19 million, a PE ratio of 42.80 and a beta of 1.10. The business has a fifty day moving average of $27.36 and a 200-day moving average of $26.16. Global X HealthTech ETF has a 52 week low of $23.00 and a 52 week high of $33.59.
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
See Also
- Five stocks we like better than Global X HealthTech ETF
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
